Gastroenterology Learning Network

This podcast explores the potential of new drugs, including seladelpar, for the treatment of primary biliary cholangitis (PBC). It discusses the effectiveness of seladelpar in improving liver tests, serum biochemistry, and symptom relief. The podcast also highlights the benefits of seladelpar in preventing cirrhosis and improving quality of life in PBC patients. Additionally, it addresses the safety of seladelpar and its potential in addressing symptoms such as itching, fatigue, and abdominal discomfort.

Discussion of clinical trials for inflammatory bowel disease, combination therapy and withdrawal strategies, treatment options for inflammation, IV reintroduction and subcutaneous infliximab for Crohn's disease, and the evaluation of subcutaneous infusions as an alternative treatment option.

The hosts discuss the impact of social determinants of health on access to biologic medications. They explore delays in starting effective drug therapies for inflammatory bowel disease. They highlight a study on a passive monitoring device that predicts flares in Crohn's disease. They discuss possibilities of early detection and remote monitoring for IBD, linking it to electronic medical records.

In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, on the new guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.

In a special edition of IBD Drive Time, guest host David Rubin, MD, discusses how inflammatory bowel disease can affect sexual function with his University of Chicago colleagues Alyse Bedell, PhD, GI psychologist and sex therapist, and Sarah Macareg, PhD, a pelvic floor physical therapist.

Host Brian Lacy, MD, discusses the challenges of accurately diagnosing and treating exocrine pancreatic insufficiency with guest Santhi Swaroop Vege, MD, from the Mayo Clinic in Rochester, Minnesota.

Gut Check host Brian Lacy, MD, discusses exocrine pancreatic insufficiency, including proper diagnosis and treatment, with pancreatologist Dr Santhi Vege.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Parambir Dulai about abstracts from the ECCO ’23 Congress on the role of biomarkers in the clinical care and research for inflammatory bowel disease.

Elham Afghani, MD, on the Genetic Epidemiology of Pancreatic Cancer by Gastroenterology Learning Network

Dr Barnes reviews key abstracts from ECCO 2023 on novel therapeutics for inflammatory bowel disease with hosts Drs Raymond Cross and Millie Long.